George Jackowski
73Patents
14h-index
28Co-inventors
84Inventor score
Filing activity: May 3, 1991 → Aug 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5747274A | Method and device for diagnosing and distinguishing chest pain in early onset thereof | Emerging Cross-Sectional Technologies | 97 | Expired |
| US5290678A | Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof | Emerging Cross-Sectional Technologies | 87 | Expired |
| US5604105A | Method and device for diagnosing and distinguishing chest pain in early onset thereof | Emerging Cross-Sectional Technologies | 81 | Expired |
| US5710008A | Method and device for diagnosing and distinguishing chest pain in early onset thereof | Emerging Cross-Sectional Technologies | 55 | Expired |
| US6890763B2 | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons | Emerging Cross-Sectional Technologies | 55 | Expired |
| US6461828B1 | Conjunctive analysis of biological marker expression for diagnosing organ failure | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5744358A | Method and device for diagnosing and distinguishing chest pain in early onset thereof | Emerging Cross-Sectional Technologies | 35 | Expired |
| US7527939B2 | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP | Emerging Cross-Sectional Technologies | 31 | Expired |
| USRE39816E1 | Conjunctive analysis of biological marker expression for predicting cardiac mortality | General | 26 | Expired |
| US6235489A | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7374950B2 | Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | Emerging Cross-Sectional Technologies | 21 | Active |
| US7179606B2 | IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5702905A | Monoclonal antibody to human ventricular myosin light chains | Chemistry; Metallurgy | 17 | Expired |
| US5573957A | Monoclonal antibody to human cardiac myoglobin | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6780606B1 | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein | Physics | 13 | Expired |
| US6602855B2 | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6617308B2 | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6451547B1 | Process for differential diagnosis of Alzheimer's dementia and device therefor | Physics | 9 | Expired |
| US6627606B2 | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6620786B2 | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6593298B2 | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6703366B2 | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5560937A | Method for purification of cardiac troponin I | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6620787B2 | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7329501B2 | Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance | Emerging Cross-Sectional Technologies | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.